Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you be comfortable offering breast + RNI to a 60 y/o F who had a recent ischemic stroke 1 month ago? Would you counsel about any risk for future stroke?
Related Questions
How would you manage a patient presenting with recurrent cT4 breast cancer?
What hotspot and heterogeneity metrics do you utilize when delivering PMRT to a patient who has had breast reconstruction?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
When do you consider the addition of concurrent pembrolizumab to breast irradiation?
Do you start systemic therapy for patients with previously localized HR+ breast cancer developing solitary bone metastasis which is now triple negative if there are no other sites of disease after metastasis-directed radiation?
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
Would you offer reirradiation for a patient who had prior MammoSite PBI?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
Do you test /back project various bolus such as mesh or superflab to verify dosimetry and which do you prefer? How do you have staff apply it consistently? eg mesh bolus for chest wall
